The hospital chain’s stock price traded as low as $2.85 on July 13 after closing July 12 at $2.92 per share. CHS’ shares have lost 35 percent of their value in the past month, since hitting $4.41 June 15.
CHS’ share price began sinking in late June after the company priced a new offering of approximately $1.03 billion of senior secured notes. The company intends to use the proceeds to pay off about $1.01 billion in outstanding term loans and related expenses.
More articles on healthcare finance:
CMS releases proposed physician payment rule for 2019: 6 things to know
OIG tags Wisconsin hospital for erroneous billing
Chicago hospital needs $3M infusion to avoid closure
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
